Helping Patients Anticipate and Manage Drug Costs

As local and national legislators and regulators consider ways to curb the rising cost of pharmaceuticals, what remains unknown are the intended and unintended consequences to patients of proposed actions, including potential changes to rebates for federal programs, requirements for public disclosure and transparency of drug prices, and the role of PBMs and health plans. Participants considered the possible solutions for addressing rising costs and discuss challenges, practical steps for implementing point of sale rebates and other proposed solutions, and discussed how patient assistance programs and copay policies fit into the affordability equation. This forum will develop recommendations and possible solutions to improve price transparency, address the rising costs of medications, and help patient understand and manage drug cost.

Additional Materials:

• Forum Program [PDF]
• Press Release 
• Executive Summary  [PDF]
• Forum Proceedings 
• Forum Webinar